Philly.com As opioid deaths rise, pharma firm hikes price of antidote more than six-fold Still, experts say the device’s price surge is way out of step with production costs, and a needless drain on health-care resources. “There’s absolutely nothing that warrants them charging what they’re charging,” said Leo Beletsky, an associate professor of law and health sciences at Northeastern University in Boston.